Human papillomavirus vaccines: WHO position paper
- 31 October 2009
- journal article
- review article
- Published by Elsevier in Biologicals
- Vol. 37 (5) , 338-344
- https://doi.org/10.1016/j.biologicals.2009.04.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Imaging of the anterior segment in glaucomaClinical & Experimental Ophthalmology, 2009
- Cost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: A literature reviewVaccine, 2008
- Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of ageGynecologic Oncology, 2008
- Modeling Cervical Cancer Prevention in Developed CountriesVaccine, 2008
- Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implicationsReproductive Health Matters, 2008
- Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV InfectionThe Journal of Infectious Diseases, 2007
- The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource settingBritish Journal of Cancer, 2007
- Journal Self-Study CEUsCommunication Disorders Quarterly, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling AnalysesPLoS Medicine, 2006